Archivo del sitio

Childhood pemphigus vulgaris successfully treated with rituximab

Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an

Etiquetado con: , ,
Publicado en: Todo el mundo, Noticias e información

Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases

Rituximab has been reported to be effective in various small case series of patients with severe and/or refractory pemphigus. However, no systematic evaluation is available to corroborate this observation. The aim of this study was to systematically determine efficacy and

Etiquetado con: , ,
Publicado en: Todo el mundo, P - P paciente registro, Investigación basada en el registro

UNIRSE HOY!

El registro de p y p ha sido aprobado por la Junta de revisión institucional de occidental (WIRB) y activamente es inscribir participantes.

VERSIÓN EN INGLÉS

VERSIÓN EN ESPAÑOL